XNAS
MMED
Market cap4.98bUSD
Oct 23, Last price
18.34USD
1D
0.27%
1Q
8.97%
IPO
1.89%
Name
MiniMed Group Inc
Chart & performance
P/E
—
P/S
—
EPS
—
Vol. 1Y
—
Shs. 5Y
—
Rev. 5Y
%
Div Yld LY
—
Div Yld TTM
—
Revenues
3.10b
0.00%
Net income
-331m
L-0.00%
CFO
-197m
L
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
MiniMed Group, Inc. is a medical technology company that develops, manufactures, and markets a comprehensive suite of solutions for the management of diabetes. Its products include insulin delivery devices like pumps and pens, continuous glucose monitors, and related software and services. The company serves people with diabetes who require insulin therapy across more than 80 countries.
Valuation
Title in thousands, except ratios and share amounts | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| 2026‑04 | 2026‑04 | 2025‑04 | 2024‑04 | 2023‑04 | |
| Income | |||||
Revenues | |||||
Cost of revenue | |||||
Unusual Expense (Income) | |||||
NOPBT | |||||
NOPBT Margin | |||||
Operating Taxes | |||||
Tax Rate | |||||
NOPAT | |||||
Net income | |||||
Dividends | |||||
Dividend yield | |||||
Proceeds from repurchase of equity | |||||
BB yield | |||||
| Debt | |||||
Debt current | |||||
Long-term debt | |||||
Deferred revenue | |||||
Other long-term liabilities | |||||
Net debt | |||||
| Cash flow | |||||
Cash from operating activities | |||||
CAPEX | |||||
Cash from investing activities | |||||
Cash from financing activities | |||||
FCF | |||||
| Balance | |||||
Cash | |||||
Long term investments | |||||
Excess cash | |||||
Stockholders' equity | |||||
Invested Capital | |||||
ROIC | |||||
ROCE | |||||
| EV | |||||
Common stock shares outstanding | |||||
Price | |||||
Market cap | |||||
EV | |||||
EBITDA | |||||
EV/EBITDA | |||||
Interest | |||||
Interest/NOPBT |